We are live on ! Find out more
BOS

Bingham Osborn & Scarborough Portfolio holdings

AUM $1.42B
1-Year Est. Return 27.88%
This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.88%
3 Year Est. Return
+51.71%
5 Year Est. Return
+102.3%
10 Year Est. Return
AUM
$1.33B
AUM Growth
+$84.9M
Cap. Flow
-$24.9M
Cap. Flow %
-1.88%
Top 10 Hldgs %
78.62%
Holding
168
New
13
Increased
56
Reduced
69
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 6.38%
2 Consumer Discretionary 2.59%
3 Financials 1.67%
4 Industrials 1.45%
5 Healthcare 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEU icon
26
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
$5.46M 0.41%
108,171
-1,468
-1% -$74.5K
IEMG icon
27
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$5.31M 0.4%
100,578
+68,860
+217% +$3.61M
SCHW
28
Charles Schwab
SCHW
$187B
$4.11M 0.31%
113,557
-115
-0.1% -$4K
BRK.B icon
29
Berkshire Hathaway Class B
BRK.B
$1.13T
$4.11M 0.31%
19,290
-1,072
-5% -$219K
WORK
30
DELISTED
Slack Technologies, Inc.
WORK
$3.49M 0.26%
129,852
+742
+0.6% +$21.8K
META icon
31
Meta Platforms (Facebook)
META
$1.51T
$3.4M 0.26%
12,980
+559
+5% +$144K
CRM icon
32
Salesforce
CRM
$158B
$3.29M 0.25%
13,077
-54
-0.4% -$11.8K
WFC icon
33
Wells Fargo
WFC
$264B
$3.19M 0.24%
135,671
-299
-0.2% -$7.37K
BAC icon
34
Bank of America
BAC
$442B
$2.85M 0.22%
118,449
-699
-0.6% -$17.4K
XLK icon
35
State Street Technology Select Sector SPDR ETF
XLK
$123B
$2.65M 0.2%
45,506
-5,962
-12% -$337K
ORCL icon
36
Oracle
ORCL
$423B
$2.39M 0.18%
39,959
-11,076
-22% -$629K
EFV icon
37
iShares MSCI EAFE Value ETF
EFV
$30.2B
$2.34M 0.18%
58,091
+4,605
+9% +$190K
JAZZ icon
38
Jazz Pharmaceuticals
JAZZ
$16.7B
$2.2M 0.17%
15,436
IVE icon
39
iShares S&P 500 Value ETF
IVE
$49.8B
$2.17M 0.16%
19,300
+10,878
+129% +$1.23M
PG icon
40
Procter & Gamble
PG
$339B
$2.16M 0.16%
15,553
-54,521
-78% -$7.24M
IDV icon
41
iShares International Select Dividend ETF
IDV
$8.57B
$2.03M 0.15%
81,545
+271
+0.3% +$7.03K
SPYX icon
42
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.88B
$1.94M 0.15%
69,738
+387
+0.6% +$10.6K
KR icon
43
Kroger
KR
$34.8B
$1.81M 0.14%
53,493
-9
-0% -$311
JNJ icon
44
Johnson & Johnson
JNJ
$625B
$1.7M 0.13%
11,424
+403
+4% +$59.6K
JPM icon
45
JPMorgan Chase
JPM
$950B
$1.7M 0.13%
17,658
+316
+2% +$31K
ABBV icon
46
AbbVie
ABBV
$435B
$1.68M 0.13%
19,173
+229
+1% +$21.6K
ABT icon
47
Abbott
ABT
$187B
$1.63M 0.12%
14,985
+30
+0.2% +$3.04K
BRK.A icon
48
Berkshire Hathaway Class A
BRK.A
$1.12T
$1.6M 0.12%
5
GOOGL icon
49
Alphabet (Google) Class A
GOOGL
$4.33T
$1.6M 0.12%
21,820
-240
-1% -$18.3K
WTW icon
50
Willis Towers Watson
WTW
$32B
$1.53M 0.12%
7,324

Similar funds

Bingham Osborn & Scarborough's Q3 2020 Portfolio in Review

As of Q3 2020, Bingham Osborn & Scarborough held 168 positions worth $1.33B, up 6.8% from $1.24B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Bingham Osborn & Scarborough's Q3 2020 filing shows 13 new, 56 increased, 69 reduced and 6 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 10,450 shares worth $1.02M. The largest sale was Procter & Gamble, an estimated $7.24M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 6% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Bingham Osborn & Scarborough's largest Q3 2020 buy was GW Pharmaceuticals Plc American Depositary Shares: 10,450 shares worth $1.02M.
  • Bingham Osborn & Scarborough added most to iShares Core MSCI Emerging Markets ETF in Q3 2020, an estimated $3.61M increase.
  • Bingham Osborn & Scarborough's biggest Q3 2020 reduction was Procter & Gamble, cutting an estimated $7.24M.
  • Bingham Osborn & Scarborough fully exited Emerson Electric in Q3 2020, selling an estimated $330K.
  • Bingham Osborn & Scarborough's ten largest holdings make up 79% of its $1.33B portfolio in Q3 2020.
  • Bingham Osborn & Scarborough opened 13 new positions and closed 6 in Q3 2020.
  • Bingham Osborn & Scarborough's portfolio value rose 6.8% quarter-over-quarter to $1.33B.

Based on Bingham Osborn & Scarborough's 13F filing for Q3 2020, filed 4 Nov 2020.